This standards-driven approach, supported by Study Data Mapper, has improved the quality of study data production and helped achieve a considerable reduction in custom programming through the re-use of standard data models and transformations.
San Mateo, CA (PRWEB) September 24, 2013
BioPharm Systems, a leading global IT consulting and managed services provider (MSP) specializing in Oracle's clinical trial, data, safety, and pharmacovigilance management systems, today announced that it has been awarded the 2013 Award for Excellence in Results from the Oracle Health Sciences User Group (OHSUG) for the development and implementation of Study Data Mapper for ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. This award, presented at the 18th Annual OHSUG Meeting in Miami, Florida on September 23, 2013, recognizes organizations that have designed and implemented a significant advancement, which has increased an organization's operational efficiencies and best practices.
Following the successful implementation of Oracle Life Sciences Data Hub (LSH) in 2010, ICON was seeking a solution that was capable of integrating, consolidating, and transforming raw clinical data from diverse systems and data structures into a variety of structures optimized for reporting, analysis or submission. Based on these requirements, BioPharm developed Study Data Mapper.
Study Data Mapper uses metadata to support the:
-- Management of standard data models and study variations
-- Capture and management of data transformation metadata
-- Generation of standalone SAS programming code that creates the target data structure and the supporting ETL to conform into the target standard
"This standards-driven approach, supported by Study Data Mapper, has improved the quality of study data production and helped achieve a considerable reduction in custom programming through the re-use of standard data models and transformations," said Paul Crean, clinical data services development manager, ICON plc.
"We are very pleased with the benefits ICON has achieved with Study Data Mapper," said Mike Grossman, vice president of clinical data warehousing and analytics, BioPharm. "Study Data Mapper was specifically created for companies seeking to streamline and automate the process of preparing clinical trial data for analysis, reporting, and submission."
BioPharm is a Gold level member of Oracle PartnerNetwork (OPN) and an Oracle Accelerate solution provider. The company has achieved Specializations in Oracle Argus Safety Suite, Oracle Life Sciences Data Hub, and Oracle Accelerate for Midsize Companies.
About Oracle PartnerNetwork
Oracle PartnerNetwork (OPN) Specialized is the latest version of Oracle's partner program that provides partners with tools to better develop, sell and implement Oracle solutions. OPN Specialized offers resources to train and support specialized knowledge of Oracle products and solutions and has evolved to recognize Oracle's growing product portfolio, partner base and business opportunity. Key to the latest enhancements to OPN is the ability for partners to differentiate through Specializations. Specializations are achieved through competency development, business results, expertise, and proven success. To find out more, visit oracle.com/partners.
About Oracle Accelerate
Oracle Accelerate provides simple to deploy, packaged, enterprise-class software solutions to growing midsize organizations through Oracle’s network of expert partners. Oracle Accelerate solutions enable growing midsize organizations to easily adopt Oracle's enterprise class software. Created by Oracle's expert partners, Oracle Accelerate solutions are simple to deploy, industry-specific packaged solutions, designed for fast time to benefit, which means getting the right solution in place quickly, inexpensively with a controlled scope and predictable returns. The best Oracle Accelerate Solutions are based on Oracle Business Accelerators, which are advanced implementation tools, created and maintained by Oracle. To find out more, visit oracle.com/accelerate.
About BioPharm Systems
BioPharm Systems (http://www.biopharm.com) is a global IT consulting and managed services provider (MSP) that focuses on the life sciences industry. We have extensive experience in the implementation, integration, migration, upgrade, and hosting of the following Oracle clinical trial management, drug safety and pharmacovigilance, clinical data warehousing and analytics, clinical data management, and electronic data capture systems: ClearTrial, Siebel Clinical, LabPas, Argus Safety Suite (Argus Safety, Argus Safety Japan, Affiliate, Interchange, Reconciliation, Dossier, Insight, and Perceptive), Adverse Event Reporting System (AERS), Empirica Signal, Empirica Topics, Life Sciences Data Hub (LSH), Clinical Development Analytics (CDA), Oracle Clinical, Remote Data Capture (RDC), and Thesaurus Management System (TMS).
Founded in 1995 and headquartered in California, BioPharm Systems has offices in the United States and the United Kingdom. To learn more about the company's products and services, please call +1 877 654 0033 (U.S.), +44 (0) 1865 910200 (U.K.), or e-mail info(at)biopharm(dot)com.
Oracle and Java are registered trademarks of Oracle and/or its affiliates.
North America Sales Contacts:
Vice President of Sales, Trial Management Solutions
+1 877 654 0033
Vice President of Sales, Data Management Solutions
+1 877 654 0033
Europe/Middle East/Africa Sales Contact:
Director of Business Development, EMEA
+44 (0) 1865 910200
Marketing Communications Manager
+1 617 795 2032
Google Plus: plus.google.com/104105608638786200757